Neidio i'r prif gynnwy

Pob Dogfen Bolisi

Teitl
 CP05a Management of Patients with Inherited Bleeding Disorders including Haemophilia.pdf (PDF, 245Kb)
 CP05b Management of Patients with Inherited Bleeding Disorders including Haemophilia.pdf (PDF, 263Kb)
 CP179 Sickle Cell Disorders, Thalassaemia Disorders and other Rare Hereditary Anaemias all ages.pdf (PDF, 530Kb)
 CP193 Cystic Fibrosis Adults and Young People.pdf (PDF, 658Kb)
 CP35 Cochlear Implant for children and adults with.pdf (PDF, 259Kb)
 CP57b Genetic Testing for Inherited Cardiac Conditions.pdf (PDF, 387Kb)
 CP58 Trans-catheter Aortic Valve Implantation (TAVI) for Severe Symptomatic Aortic Stenosis (SSAS) Commissioning Policy.pdf (PDF, 172Kb)
 CP58 Trans-catheter Aortic Valve Implantation (TAVI) for Severe Symptomatic Aortic Stenosis (SSAS).pdf (PDF, 214Kb)
 CP78 Specialised Immunology.pdf (PDF, 630Kb)
 CP99 Genetic Services.pdf (PDF, 410Kb)
 PP102 Extra Corporeal Membrane Oxygenation (ECMO) service for adults with cardiac failure..pdf (PDF, 213Kb)
 PP102 Extra Corporeal Membrane Oxygenation (ECMO) service for adults with cardiac failure.pdf (PDF, 116Kb)
 PP103 Everolimus for the prevention of organ rejection following heart transplantation.pdf (PDF, 119Kb)
 PP103 Everolimus for the prevention of organ rejection info.pdf (PDF, 213Kb)
 PP104 Personalised External Aortic Root Support (PEARS) for surgical management of enlarged aortic root (adults).pdf (PDF, 148Kb)
 PP104 Personalised External Aortic Root Support (PEARS) info.pdf (PDF, 216Kb)
 PP105 Selexipag for the Treatment of Pulmonary Arterial Hypertension (adults).pdf (PDF, 185Kb)
 PP105 Selexipag for the Treatment of Pulmonary info.pdf (PDF, 169Kb)
 PP151 Complex Devices Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure.pdf (PDF, 177Kb)
 PP151 info.pdf (PDF, 216Kb)
 PP162 Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (all ages).pdf (PDF, 186Kb)
 PP162 info.pdf (PDF, 216Kb)
 PP167 Emicizumab as prophylaxis in people with congenital haemophilia A with Factor VIII inhibitors (all ages).pdf (PDF, 297Kb)
 PP184 Genomic Testing.pdf (PDF, 239Kb)
 PP189 Emicizumab as prophylaxis in people with severe congenital haemophilia.pdf (PDF, 271Kb)
 PP189 Emicizumab as prophylaxis in people with severe congenital haemophilia1.pdf (PDF, 79Kb)
 PP198 Cystic Fibrosis Modulator Therapies.pdf (PDF, 597Kb)